Understanding cell behaviour at a systems level is largely concealed due to limited knowledge of proteome dynamics. Changes in the expression of proteins and their cognate mRNAs display positive, yet only modest correlation^[@R1],\ [@R2]^, the highest correlation being observed for components of conserved molecular machines^[@R3]^. Indeed, abundance of cellular proteins may be predominantly controlled at the translation level^[@R4]^. Thus, knowledge of transcriptomes' dynamics alone is evidently insufficient to understand cell behaviour. SILAC-based MS analysis permits quantitation of steady-state proteome changes^[@R5]^. However, monitoring the proteome response to stimuli remains challenging, especially for *ex vivo* primary cells, to which SILAC cannot be straightforwardly applied^[@R6]^. Likewise, quantifying immediate/early changes of protein networks occurring during complex biological processes (such as cell proliferation and differentiation), is problematic because short SILAC pulses (few hours) label only a small fraction of a protein pool^[@R7]^, severely limiting MS-based quantitation of protein expression changes. Selective isolation of the fraction of SILAC-labelled proteins would help to overcome the above limitations. BONCAT exploits Cu(I)-catalysed azide-alkyne cycloaddition (CuAAC) for site-selective labelling of newly synthesised proteins^[@R8]^, without modifying the translation machinery by genetic engineering. Cells are cultured in the presence of the azide-bearing methionine surrogate azidohomoalanine (AHA), which is efficiently incorporated into newly synthesized proteins without adverse effects on cellular functions^[@R8],\ [@R9]^. After cell lysis, the AHA azide group is reacted with an alkyne-bearing biotinylated tag in the presence of CuAAC catalyst, allowing for the selective enrichment of the tagged protein pool. BONCAT has been used for MS-based non-quantitative monitoring of newly synthesized proteins in cultured mammalian cells^[@R9]^. However, the efficiency and rate of CuAAC is site-and protein-dependent and may not be homogeneous for all proteins^[@R10],\ [@R11]^. Moreover, monitoring protein changes by BONCAT alone using label-free MS-based quantitation would have low accuracy.

To overcome the technical limitations of BONCAT and pulsed-SILAC, we have combined their strengths in Quantitative Non Canonical Amino acid Tagging (QuaNCAT) ([Fig. 1](#F1){ref-type="fig"}). To test its feasibility and sensitivity, we applied QuaNCAT to freshly isolated human CD4 T cells (hCD4^+^) stimulated by Phorbol 12-myristate 13-acetate (PMA) and ionomycin. These drugs closely mimic cellular activation by antigen and co-stimuli, thereby eliciting proliferation and differentiation. hCD4^+^ cells were starved for 60 min in Met-, Arg- and Lys-depleted medium and then cultured for 2 and 4 h with 1 mM AHA and either 'heavy' \[^13^C~6~,^15^N~4~\]-L-Arg and \[^13^C~6~,^15^N~2~\]-L-Lys, for stimulated cells, or with 'medium' \[^13^C~6~\]-L-Arg and \[^2^H~4~\]-L-Lys, for non-stimulated cells ([Fig. 1](#F1){ref-type="fig"}). This labelling strategy ensured straightforward distinction by MS of stimulation-induced ('heavy-labelled') from steady-state ('medium-labelled') synthesised proteins. 1 mM AHA pulse for up to a maximum of 4 h did not cause significant changes in T cell morphology and viability ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). As examined in Jurkat T cells, these pulse conditions had no significant effect on the rate of protein synthesis as compared to Met-pulsed cells and proteins containing AHA or Met had very similar degradation rates ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}).

We mixed non-stimulated and stimulated cells in a 1:1 ratio and extracted proteins by SDS, boiling, followed by, reduction, alkylation and performed the CuAAC reaction with an alkyne-containing biotinylated cleavable linker^[@R12]^ ([Fig.1](#F1){ref-type="fig"}). An optimised CuAAC protocol with Cu(I)-ligand complex proved superior to using Cu(II)/ascorbate (see Methods), with enhanced rate (\<2 h) and reduced reactive oxygen species damage to proteins. After removal of excess alkyne tag, biotin-tagged proteins were bound to NeutrAvidin-immobilized beads and non-specifically bound proteins removed by thorough washing. Anti-biotin antibody immunoblots confirmed effective biotin labelling of AHA-containing proteins and their enrichment after NeutrAvidin binding (data not shown). Biotin-tagged proteins were eluted from NeutrAvidin with DTT ([Fig.1](#F1){ref-type="fig"}), substantially reducing the MS signal from contaminating unlabelled ('light') proteins. Eluted proteins digested by trypsin were analysed by nanoLC-MS/MS by injecting each sample three times. Simultaneous AHA and stable isotope labelling with Arg and Lys, followed by biotin tagging, allowed for strong enrichment and quantitation of newly synthesised proteins to determine stimuli-induced changes in their abundance. The peak intensities of 'medium' (M) and 'heavy' (H) peptide pairs ([Fig. 1](#F1){ref-type="fig"}) were quantified using both Proteome Discoverer 1.3™ and MaxQuant 1.3.0.5 software^[@R13]^ (see [Online Methods](#S2){ref-type="sec"} and [Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). Fold induction for each quantitated protein after 2 h and 4 h stimulation and standard deviation (SD), obtained from three independent experimental replicates (and three MS analysis for each one) is shown in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}. Comparisons of individual data sets (9) to each other (Pearson correlation coefficient, [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}), indicated good overall experimental reproducibility. Consistently, experimental replicates for 2 h and 4 h stimulations showed 95% and 89% coincidence for 410 and 550 quantified proteins, respectively ([Supplementary Fig. 5a-c](#SD1){ref-type="supplementary-material"}). [Fig 2a](#F2){ref-type="fig"} shows value-ordered plots for 410 and 550 proteins quantified at 2 h and 4 h of stimulation, respectively. These data were analysed with the LIMMA statistical package^[@R14]^, which provided fold change with associated *P*-value for differential expression of each protein, as shown in [Fig. 2b](#F2){ref-type="fig"}. Quantitation of differentially expressed proteins (*P*-value \< 0.05) was validated by manual inspection of the mass spectra. [Supplementary Table 2](#SD1){ref-type="supplementary-material"} and [Fig. 3](#F3){ref-type="fig"} show the 107 manually validated differentially expressed proteins, 93 of which show an increase after T cell stimulation. 56 proteins were differentially expressed already at 2 h, 33 of which (\~60%) were still differentially expressed (increased or decreased) at 4 h (Venn diagrams next to [Supplementary Table 2](#SD1){ref-type="supplementary-material"}), further indicating the robustness of the QuaNCAT protocol. 50 proteins of 107 were differentially expressed only after 4 h of stimulation. Fold increases showed a dynamic range extending from 1.6 to 589 fold, with 72 (of 141) measured changes being ≥ 5 fold. Some of the largest fold changes likely represent instances of *de novo* protein expression. Gene ontology analysis of molecular function of differentially expressed proteins ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}) revealed that a large number are involved in transcription regulation, including pre- and post-transcriptional processes. This is consistent with transcriptome studies of activated human T cells^[@R15]^, which have revealed the transition of weakly metabolically active T cells in G~0~ to proliferation and differentiation into immune response effectors. Consistently, QuaNCAT detected substantial increases (5 to 500 fold) in expression at 2 h and/or 4 h of several immediate early/early genes, many of which encode transcription factors and transcriptional regulators (such as Fos, Jun, NR4A, IRF and EGR family members, c-Rel, FOXp1 and a lysine-specific demethylase, [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"} and [Fig. 3](#F3){ref-type="fig"}). Others included cytokines (INFγ and CSF2) and activation surface markers (CD69, CD97, HLA), protein chaperones, proteins involved in cytoskeleton dynamics and vesicle transport. Of note, was the detection of significant increases (2 to 20 fold) of several proteins that regulate mRNA metabolism, translation and the cell cycle. Some proteins were not annotated and/or not previously detected during T cell activation and it will be particularly interesting to unravel their role in T cell proliferation and/or differentiation ([Fig. 3](#F3){ref-type="fig"}). QuaNCAT data also revealed decreased expression of several proteins, perhaps caused by transcription and/or translation attenuation or accelerated protein degradation. The latter two mechanisms, as well as their reverse trends (increase in mRNA translatability and protein stability) would escape transcriptome analysis but can be detected by QuaNCAT. An interaction network of proteins differentially expressed at 2 and 4 h illustrates that more than half are interlinked by functional and biochemical networks ([Fig. 3](#F3){ref-type="fig"}).

The use of 'medium' and 'heavy' SILAC overcame potential confounding effects in quantitation due to persistent signals from 'light' peptides, likely derived from contaminating untagged pre-existing proteins. After affinity purification, 'heavy'- and 'medium'-labelled proteins typically represented 10-20 % in hCD4^+^ T cells (data not shown), a substantial enrichment, as only \<\< 1% of total proteins were labelled after a 2 h pulse.

The ability to quantitate relative differences in abundance of many cellular proteins reveals the power of QuaNCAT and should be applicable to shorter and longer kinetics. However, long-term methionine starvation affects cellular methylation of proteins and nucleic acids and prolonged AHA pulses could be sensed by the cellular machinery as some proteins may be affected by AHA incorporation. We did not notice stress in T cells when pulsed for up to 4 h with AHA, but longer pulses certainly require one to carefully evaluate potential toxicity effects. Application of QuaNCAT for relatively short times after cellular perturbations should enable quantitative monitoring of the most dynamic pool of the proteome, which is likely to be the one of most biological interest. Moreover, 2-4 h of AHA/SILAC pulse-labelling applied several hours after cell stimulation would also allow one to monitor proteomic changes at late stimulation time points and avoid adverse effects due to lengthy methionine starvation.

QuaNCAT is a much sought-after complement to the analysis of transcriptome dynamics. Its combination with targeted MS-based quantitation could help to assess absolute changes in protein expression with further accuracy and sensitivity.

Online Methods {#S2}
==============

Labelling cells with SILAC amino acids and Aha {#S3}
----------------------------------------------

Primary human CD4 T-lymphocytes were isolated from blood by negative selection (Dynal isolation kit, Invitrogen). Primary T-lymphocytes were rested overnight in RPMI 1640 media (PAA) supplemented with 10% FBS (Gibco). Purity of isolated cells was assessed by analysing CD3 and CD4 surface expression using flow cytometry (data not shown). For metabolic labelling, cells were starved of methionine, arginine and lysine for 1 hour at 37 °C in RPMI SILAC media (Dundee Cell Products) supplemented with 10 % dialysed FBS at a cell density of 2×10^6^/ml. After centrifugation, cells were equally divided into two sets. One set of cells was resuspended in fresh RPMI SILAC media containing 1.14 mM 'medium' arginine (^13^C~6~-L-arginine) and 0.219 mM 'medium' lysine (^2^H~4~-L-lysine) while the other set of cells was placed in 1.14 mM 'heavy' arginine (^13^C~6~,^15^N~4~-L-arginine) and 0.219 mM 'heavy' lysine (^13^C~6~,^15^N~2~-L-lysine) (CK Gas Products Ltd). In order to minimise arginine to proline conversion, RPMI SILAC media was supplemented with 1.7 mM L-proline. L-azidohomoalanine (AHA) was added to each set of cells to a final concentration of 1 mM. Cells in the heavy medium were stimulated by adding PMA at 62.5 ng/ml (100 nM) and Ionomycin at 1 μg/ml (1.4 μM). Efficient stimulation was verified by CD69-surface staining and flow cytometry (data not shown). Cells were incubated for 2 and 4 hours at 37 °C before being harvested by centrifugation.

Protein extraction, reduction and alkylation {#S4}
--------------------------------------------

For each replicate, 90×10^6^ 'heavy'-stimulated and 90×10^6^ 'medium'-unstimulated labelled primary cells were harvested by centrifugation, washed in PBS, and combined. Cells were lysed in 500 μL 1% SDS in PBS containing protease and phosphatase inhibitors (Complete EDTA-free, Roche, 2mM sodium pervanadate) by rigorous vortexing. Lysate was boiled at 100°C for 10 minutes, after which 1000 units of benzonase (Sigma) was added and the sample was incubated at room temperature for 15 minutes. The lysate was cleared by centrifugation at 20,000g for 10 minutes at 4 °C. 10 mM TCEP (Thermo) was added to each sample and incubated at 55 °C for 45 minutes to reduced proteins. After cooling down the sample, pH was adjusted to 8 by sodium hydroxide before addition of iodoacetamide to a final concentration of 18 mM. Proteins were alkylated by incubation at room temperature for 30 minutes in the dark. Each lysate was desalted before biotinylation using spin desalting columns (Zeba™ 7kDa MWCO, Thermo).

Copper-catalysed Huisgen cycloaddition of protein samples with biotinylated-alkyne label {#S5}
----------------------------------------------------------------------------------------

The protocol used has previously been optimized by van Kasteren et al^\[[@R10]\]^ and was applied universally to all samples as follows. A freshly prepared solution of copper(I) bromide (99.999% purity) in acetonitrile (163 μL, 10 mg/mL) was premixed with an acetonitrile solution of tris-triazolyl amine ligand (63 μL, 127 mg/mL). For cycloaddition 7 μL of the biotin-alkyne disulfide probe^\[[@R12]\]^ (25 mM stock solution in PBS at pH 7.8, 87.5 nmol) was added to 540 μL of reduced, alkylated and desalted protein lysate from each replicate and mixed. 30 μL of the preformed Cu(I)-Ligand complex solution was added to the mixture and mixed thoroughly. The reaction was performed in 1.5 ml reaction tubes on an end-over-end rotator for 90 minutes at room temperature. Tubes were centrifuged at 2,000g for 5 minutes and the supernatant was purified by desalting columns (Zeba™ 7kDa MWCO, Thermo).

Pull-down of biotinylated proteins {#S6}
----------------------------------

For each replicate, 40 μL of High Capacity Neutravidin® resin (Thermo) was washed three times in 1 mL 0.05 %SDS in PBS. After the final wash the supernatant was discarded and 577 μl of the desalted lysate was added to the reaction tubes containing the beads and incubated at room temperature overnight on an end-over-end rotator. Samples were loaded into Pierce® Spin Columns (Thermo) and beads were collected by centrifugation. Beads were washed three times with 600 μL of each of the following buffers: 4 M Urea, 6 M Urea, 10 % acetonitrile, 20 % acetonitrile. For each washing step, beads were incubated for 5 min before spinning and collecting. Proteins were then eluted from the Neutravidin® beads through reductive cleavage as follows: 50 μL of elution buffer (20 mM DTT, 1 M Urea, 50 mM (NH~4~)HCO~3~) was added to the column and incubated with the beads for 10 minutes before spinning down and collecting the eluted proteins. This step was repeated two times. CaCl~2~ was added to a final concentration of 1.25 mM in the eluate before overnight in solution digestion of proteins with trypsin at 37°C. Peptides were desalted using C18 desalting tips. Desalted, dried peptides were then resuspended in 0.1%TFA/ 2%ACN and sonicated before analysis by mass spectrometry.

Mass spectrometry and data analysis {#S7}
-----------------------------------

Samples were analysed on an Ultimate 3000 RSLCnano (Dionex) system run in direct injection coupled to a QExactive mass spectrometer (Thermo Scientific). Samples were resolved on a NanoEASY (Thermo Scientific) C~18~-reversed phase column (50 cm long, 75 μm internal diameter, 2 μm beads) at a flow rate of 300 nL min^−1^ using a linear gradient of 5--44% buffer B (80% acetonitrile/0.1% formic acid) over 190 min. The mass spectrometer was operated in a "Top 10" data-dependent acquisition mode with dynamic exclusion enabled (40 s). Survey scans (mass range 300-1650 Th) were acquired at a resolution of 70,000 at 200 Th with the ten most abundant multiply charged (z ≥ 2) ions selected with a 3-Th isolation window for HCD fragmentation. MS/MS scans were acquired at a resolution of 17,500 at 200 Th.

Raw data were processed using MaxQuant^[@R13]^ 1.3.0.5 and Proteome Discoverer 1.3 (Thermo Scientific). Searches against the UniProt^[@R16]^ human database were performed using Andromeda^[@R17]^ and Mascot^[@R18]^ respectively. Search parameters were two missed trypsin cleavage sites, cysteine carbamidomethylation fixed modification, methionine oxidation and N-terminal protein acetylation variable modifications. Peptide results were filtered to 1% false discovery rate by MaxQuant and Proteome Discoverer.

Protein and peptide quantitation information were extracted from MaxQuant and Proteome Discoverer and imported into R 2.15.1^[@R19]^. Protein extracted ion chromatograms (XICs) were used from MaxQuant without further modification. For Proteome Discoverer, "Medium" and "Heavy" protein XICs were calculated from the sum of the individual unique peptides XICs in R^[@R20]^. Peptides with zero Medium and Heavy XICs were not considered for the calculation.

Proteins that were not reproducibly quantified across replicates were removed from downstream analysis. We required proteins to have a minimum of three quantifiable unique peptides in at least two of the three biological replicates.

Differential protein expression analysis was performed with LIMMA 3.14.1/Bioconductor^[@R14]^. After protein area distributions were quantile normalized^[@R21]^, a linear model was fitted and a moderated t-test used to assess the statistical significance of Heavy-to-Medium Protein fold changes^[@R22]^. Proteins with a corresponding fold-change *P* value (adjusted for multiple hypothesis testing with the Benjamini-Hochberg method^[@R23]^) lower than 0.05 were accepted as differentially expressed.
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###### Editorial Summary

Combining a method to label newly distinguish two populations in cell culture allows quantitative assessment of synthesized proteins with a strategy to protein dynamics.

![QuaNCAT workflow\
Cells were metabolically labelled with a combination of Azidohomoalanine (AHA) and stable isotope-containing \[^13^C~6~\]-L-Arg and \[^2^H~4~\]-L-Lys (Medium,) or \[^13^C~6~,^15^N~4~\]-L-Arg and \[^13^C~6~,^15^N~2~\]-L-Lys (Heavy,) and left non-stimulated or stimulated for 2 or 4 h, respectively and processed as indicated \[see also [Online Methods](#S2){ref-type="sec"}\].](emss-51941-f0001){#F1}

![Global changes of protein expression in primary human CD4^+^ T cells after 2 h and 4 h activation\
(**a**) Value-ordered plot of log~2~ stimulated (H)/non-stimulated (M) ratios ± 1 s.d. for each quantified protein at 2 and 4 h. H/M ratios were obtained from three independent experiments, each one including three separate nanoLC-MS/MS analyses. Differentially expressed proteins (*P* \< 0.05) are coloured orange. The top five up-regulated proteins are indicated in black. (**b**) Volcano plot of log~2~ H/M ratios vs. −log~10~ *P*-value for each quantified protein (the threshold for *P* \< 0.05 is indicated). Differentially expressed proteins (*P* \< 0.05) are coloured orange. See [online Methods](#S2){ref-type="sec"} for MS data quantitation and statistical analysis.](emss-51941-f0002){#F2}

![Interaction network of differentially expressed proteins after T cell activation for 2 and 4 hours\
An interaction network of differentially expressed proteins in primary T cells after 2 and 4 h of stimulation was constructed in MetaCore and visualised using Cytoscape. Red and blue coloured proteins indicate up- and down-regulation, respectively. Red lines: positive regulation, blue lines: negative regulation, black lines: unspecified interaction. TR, transcriptional regulation. B, binding. GR, group relation](emss-51941-f0003){#F3}
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